The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos


Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2014 Agenda and Abstracts | < Previous | Next >

2014 OMIG Abstract 8

Effect of Moxifloxacin on Fungal Keratitis
Ryan Barrett MD; Anna Lehmann; Alice Matoba MD
Department of Ophthalmology, Baylor College of Medicine, Houston, TX

Purpose: To further characterize the effect of moxifloxacin on fungal keratitis, following a previous report of cure of five cases with moxifloxacin monotherapy.

Methods: A retrospective review of patients with culture-proven fungal keratitis who were initially treated with moxifloxacin was performed. The time period studied was July 2012 through June 2014.

Results: Eleven patients who later were documented to have culture-confirmed fungal keratitis were initially treated with moxifloxacin for a variety of circumstances. Three patients (one case each of Curvularia, Alternaria, Paecilomyces) had a marked response within a few days and ultimately were cured. Eight patients had modest to no improvement and were switched to natamycin with cure.

Conclusion: Initial improvement of microbial keratitis with fluoroquinolone therapy does not rule out fungal keratitis. Moxifloxacin has some clinical antifungal effect.

Disclosure: N

2014 Agenda and Abstracts | < Previous | Next >


 

 

space